Structural Insights into the Non-additivity Effects in the Sequence-to-Reactivity Algorithm for Serine Peptidases and their Inhibitors

Journal of Molecular Biology

Volumn 367, Issue 2, 2007, Pages 527-546

  Lee, Ting Wai ^a   Qasim Jr , M A ^b   Laskowski Jr , Michael ^b   James, Michael N G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PURDUE UNIVERSITY   (United States)

Author keywords

protein protein interactions; sequence to reactivity algorithm; streptogrisin B; turkey ovomucoid third domain; X ray crystallography

Indexed keywords

ALANINE; BACTERIAL ENZYME; ENZYME INHIBITOR; GLYCINE; OVOMUCOID; PEPTIDASE; PROLINE; PROTEIN OMTKY3; PROTEIN SUBUNIT; SERINE; SERINE PEPTIDASE; STREPTOGRISIN B; UNCLASSIFIED DRUG;

ALGORITHM; AMINO ACID SEQUENCE; ARTICLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN VARIANT; SEQUENCE ANALYSIS; SEQUENCE TO REACTIVITY ALGORITHM; STEREOSPECIFICITY; STREPTOMYCES GRISEUS; STRUCTURAL PROTEOMICS; STRUCTURE ANALYSIS; TURKEY (BIRD);

STREPTOMYCES GRISEUS;

EID: 33847137690     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.01.008     Document Type: Article

References (56)

1. Anfinsen C.B. Principles that govern the folding of protein chains. Science 181 (1973) 223-230
2. Merrifield B. Solid phase synthesis. Science 232 (1986) 341-347
3. Lu S.M., Lu W., Qasim M.A., Anderson S., Apostol I., Ardelt W., et al. Predicting the reactivity of proteins from their sequence alone: Kazal family of protein inhibitors of serine proteinases. Proc. Natl Acad. Sci. USA 98 (2001) 1410-1415
4. Laskowski Jr. M., Qasim M.A., and Yi Z. Additivity-based prediction of equilibrium constants for some protein-protein associations. Curr. Opin. Struct. Biol. 13 (2003) 130-139
5. Kato I., Schrode J., Kohr W.J., and Laskowski Jr. M. Chicken ovomucoid: determination of its amino acid sequence, determination of the trypsin reactive site, and preparation of all three of its domains. Biochemistry 26 (1987) 193-201
6. Laskowski Jr. M., and Qasim M.A. What can the structures of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes?. Biochim. Biophys. Acta 1477 (2000) 324-337
7. Laskowski M.J., Qasim M.A., and Lu S.M. Interaction of standard mechanism, canonical protein inhibitors with serine proteinases. In: Kleanthous C. (Ed). Protein-Protein Recognition (2000), Oxford University Press, New York 228-279
8. Rhodes M.B., Bennett N., and Feeney R.E. The trypsin and chymotrypsin inhibitors from avian egg whites. J. Biol. Chem. 235 (1960) 1686-1693
9. Empie M.W., and Laskowski Jr. M. Thermodynamics and kinetics of single residue replacements in avian ovomucoid third domains: effect on inhibitor interactions with serine proteinases. Biochemistry 21 (1982) 2274-2284
10. Weber E., Papamokos E., Bode W., Huber R., Kato I., and Laskowski Jr. M. Crystallization, crystal structure analysis and molecular model of the third domain of Japanese quail ovomucoid, a Kazal type inhibitor. J. Mol. Biol. 149 (1981) 109-123
11. Papamokos E., Weber E., Bode W., Huber R., Empie M.W., Kato I., and Laskowski Jr. M. Crystallographic refinement of Japanese quail ovomucoid, a Kazal-type inhibitor, and model building studies of complexes with serine proteases. J. Mol. Biol. 158 (1982) 515-537
12. Bode W., Epp O., Huber R., Laskowski Jr. M., and Ardelt W. The crystal and molecular structure of the third domain of silver pheasant ovomucoid (OMSVP3). Eur. J. Biochem. 147 (1985) 387-395
13. Laskowski Jr. M., Kato I., Ardelt W., Cook J., Denton A., Empie M.W., et al. Ovomucoid third domains from 100 avian species: isolation, sequences, and hypervariability of enzyme-inhibitor contact residues. Biochemistry 26 (1987) 202-221
14. Laskowski Jr. M., Apostol I., Ardelt W., Cook J., Giletto A., Kelly C.A., et al. Amino acid sequences of ovomucoid third domain from 25 additional species of birds. J. Protein Chem. 9 (1990) 715-725
15. Apostol I., Giletto A., Komiyama T., Zhang W., and Laskowski Jr. M. Amino acid sequences of ovomucoid third domains from 27 additional species of birds. J. Protein Chem. 12 (1993) 419-433
16. Fujinaga M., Read R.J., Sielecki A., Ardelt W., Laskowski Jr. M., and James M.N.G. Refined crystal structure of the molecular complex of Streptomyces griseus protease B, a serine protease, with the third domain of the ovomucoid inhibitor from turkey. Proc. Natl Acad. Sci. USA 79 (1982) 4868-4872
17. Read R.J., Fujinaga M., Sielecki A.R., and James M.N.G. Structure of the complex of Streptomyces griseus protease B and the third domain of the turkey ovomucoid inhibitor at 1.8-Å resolution. Biochemistry 22 (1983) 4420-4433
18. Bode W., Wei A.Z., Huber R., Meyer E., Travis J., and Neumann S. X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J. 5 (1986) 2453-2458
19. Fujinaga M., Sielecki A.R., Read R.J., Ardelt W., Laskowski Jr. M., and James M.N.G. Crystal and molecular structures of the complex of alpha-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 Å resolution. J. Mol. Biol. 195 (1987) 397-418
20. Ardelt W., and Laskowski Jr. M. Turkey ovomucoid third domain inhibits eight different serine proteinases of varied specificity on the same, Leu18-Glu19. reactive site. Biochemistry 24 (1985) 5313-5320
21. Wieczorek M., Park S.J., and Laskowski Jr. M. Covalent hybrids of ovomucoid third domains made from one synthetic and one natural peptide chain. Biochem. Biophys. Res. Commun. 144 (1987) 499-504
22. Huang K., Lu W., Anderson S., Laskowski Jr. M., and James M.N.G. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B. Protein Sci. 4 (1995) 1985-1997
23. Wells J.A. Additivity of mutational effects in proteins. Biochemistry 29 (1990) 8509-8517
24. Dill K.A. Additivity principles in biochemistry. J. Biol. Chem. 272 (1997) 701-704
25. Lu W., Zhang W., Molloy S.S., Thomas G., Ryan K., Chiang Y., et al. Arg15-Lys17-Arg18 turkey ovomucoid third domain inhibits human furin. J. Biol. Chem. 268 (1993) 14583-14585
26. Qasim M.A., Lu W., Lu S.M., Ranjbar M., Yi Z., Chiang Y.W., et al. Testing of the additivity-based protein sequence to reactivity algorithm. Biochemistry 42 (2003) 6460-6466
27. Huang K. Structural studies of the interactions between serine proteinases and protein inhibitors (1995), PhD thesis, University of Alberta
28. Bateman K.S., Anderson S., Lu W., Qasim M.A., Laskowski Jr. M., and James M.N.G. Deleterious effects of beta-branched residues in the S1 specificity pocket of Streptomyces griseus proteinase B (SGPB): crystal structures of the turkey ovomucoid third domain variants Ile18I, Val18I, Thr18I, and Ser18I in complex with SGPB. Protein Sci. 9 (2000) 83-94
29. Bateman K.S. Structural studies of protein-protein interactions (1999), PhD thesis, University of Alberta
30. Park S.J. Effect of amino acid replacements in ovomucoid third domains upon their association with serine proteinases (1985), PhD thesis, Purdue University
31. Wynn R. Design of a specific human leukocyte elastase inhibitor based on ovomucoid third domains (1990), PhD thesis, Purdue University
32. Bateman K.S., Huang K., Anderson S., Lu W., Qasim M.A., Laskowski Jr. M., and James M.N.G. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-;Pro18I and OMTKY3-psi [COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi [CH2NH2+]-Asp19I. J. Mol. Biol. 305 (2001) 839-849
33. Hoogstraten C.G., Choe S., Westler W.M., and Markley J.L. Comparison of the accuracy of protein solution structures derived from conventional and network-edited NOESY data. Protein Sci. 4 (1995) 2289-2299
34. Horn J.R., Ramaswamy S., and Murphy K.P. Structure and energetics of protein-protein interactions: the role of conformational heterogeneity in OMTKY3 binding to serine proteases. J. Mol. Biol. 331 (2003) 497-508
35. Maynes J.T., Cherney M.M., Qasim M.A., Laskowski Jr. M., and James M.N.G. Structure of the subtilisin Carlsberg-OMTKY3 complex reveals two different ovomucoid conformations. Acta Crystallog. sect. D 61 (2005) 580-588
36. Lawrence M.C., and Colman P.M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234 (1993) 946-950
37. Matthews B.W. Solvent content of protein crystals. J. Mol. Biol. 33 (1968) 491-497
38. Musil D., Bode W., Huber R., Laskowski Jr. M., Lin T.Y., and Ardelt W. Refined X-ray crystal structures of the reactive site modified ovomucoid inhibitor third domains from silver pheasant (OMSVP3*) and from Japanese quail (OMJPQ3*). J. Mol. Biol. 220 (1991) 739-755
39. Radisky E.S., and Koshland Jr. D.E. A clogged gutter mechanism for protease inhibitors. Proc. Natl Acad. Sci. USA 99 (2002) 10316-10321
40. Radisky E.S., Lee J.M., Lu C.J., and Koshland Jr. D.E. Insights into the serine protease mechanism from atomic resolution structures of trypsin reaction intermediates. Proc. Natl Acad. Sci. USA 103 (2006) 6835-6840
41. Helland R., Berglund G.I., Otlewski J., Apostoluk W., Andersen O.A., Willassen N.P., and Smalas A.O. High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes. Acta Crystallog. sect. D 55 (1999) 139-148
42. Schechter I., and Berger A. On the size of the active site in proteases I. Papain. Biochem. Biophys. Res. Commun. 27 (1967) 157-162
43. Lu W., Apostol I., Qasim M.A., Warne N., Wynn R., Zhang W.L., et al. Binding of amino acid side-chains to S1 cavities of serine proteinases. J. Mol. Biol. 266 (1997) 441-461
44. Jurášek L., Carpenter M.R., Smillie L.B., Gertler A., Levy S., and Ericsson L.H. Amino acid sequence of Streptomyces griseus protease B, A MAJOR COMPONENT OF Pronase. Biochem. Biophys. Res. Commun. 61 (1974) 1095-1100
45. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. In Methods in Enzymology. In: Carter Jr. C.W., and Sweet R.M. (Eds). Macromolecular Crystallography, part A vol. 276 (1997), Academic Press, New York 307-326
46. Collaborative Computational Project, N. The CCP4 suite: programs for protein crystallography. Acta Cryst. 50 (1994) 760-763
47. Potterton E., Briggs P., Turkenburg M., and Dodson E. A graphical user interface to the CCP4 program suite. Acta Crystallog. sect. D 59 (2003) 1131-1137
48. Vagin A., and Teplyakov A. MOLREP: an automated program for molecular replacement. J. Appl. Crystallog. 30 (1997) 1022-1025
49. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallog. sect. D 53 (1997) 240-255
50. McRee D.E. XtalView/Xfit-A versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125 (1999) 156-165
51. Wallace A.C., Laskowski R.A., and Thornton J.M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8 (1995) 127-134
52. Satow Y., Cohen G.H., Padlan E.A., and Davies D.R. Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 Å. J. Mol. Biol. 190 (1986) 593-604
53. Cohen G.H. ALIGN: a program to superimpose protein coordinates, accounting for insertions and deletions. J. Appl. Crystallog. 30 (1997) 1160-1161
54. Kelley L.A., and Sutcliffe M.J. OLDERADO: on-line database of ensemble representatives and domains. On line database of ensemble representatives and DOmains. Protein Sci. 6 (1997) 2628-2630
55. Cruickshank D.W.J. Remarks about protein structure precision. Acta Crystallog. sect. D 55 (1999) 583-601
56. Brünger A.T. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355 (1992) 472-475